At the molecular level, mRNAs of TGF‐β1 and TGF‐βR2 were increased at 21 days in BLM treated WT mice as compared to NS treated WT mice, and their expressions were further enhanced in BLM treated IL‐22R−/− mice (Figure 3E–F). Here, TGFBR2 is linked to Bloom syndrome.